pharma · Chronic Lymphocytic Leukemia · Relapsing Multiple Sclerosis · TGTX
TG THERAPEUTICS
TG THERAPEUTICS, INC.
TG THERAPEUTICS clinical programs — 15 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3020 Carrington Mill Blvd, Suite 475, Morrisville, North Carolina 27560, US
- Founded
- 2011
- Employees
- 521
- Programs
- 39
- Drugs
- 23
- Patents
- 7
TG THERAPEUTICS projects
15 ClinicalTrials.gov programs sponsored by TG THERAPEUTICS.
TG THERAPEUTICS has 15 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Azercabtagene zapreleucel (azer-cel)
TG THERAPEUTICS, INC.
B-cell Mediated Autoimmune Disorders
1 trial -
Cosibelimab
TG THERAPEUTICS, INC.
B-cell Non Hodgkin Lymphoma
1 trial -
NM1F Injection
TG THERAPEUTICS, INC.
Ovarian Cancer
1 trial -
TG-1701
TG THERAPEUTICS, INC.
Non Hodgkin Lymphoma
1 trial -
TG-1801
TG THERAPEUTICS, INC.
B-Cell Lymphoma
1 trial -
TG-1801
TG THERAPEUTICS, INC.
CLL
1 trial -
TG1101-RMS-SC101
TG THERAPEUTICS, INC.
Relapsing multiple sclerosis, Myasthenia Gravis
1 trial -
TGI-5
TG THERAPEUTICS, INC.
CRC (Colorectal Cancer)
1 trial -
TGI-6 Injection
TG THERAPEUTICS, INC.
Advanced or Metastatic Solid Tumors
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Non-Hodgkin's Lymphoma
1 trial -
TGR-1202
TG THERAPEUTICS, INC.
Pancreatic Cancer
1 trial -
TGR-1202 + Obinutuzumab + Chlorambucil
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial -
TGR-1202 + brentuximab vedotin
TG THERAPEUTICS, INC.
Hodgkin's Lymphoma
1 trial -
Ublituximab + TGR-1202
TG THERAPEUTICS, INC.
Chronic Lymphocytic Leukemia
1 trial
Frequently asked questions
How many clinical projects does TG THERAPEUTICS have?
15 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.